Current status of class III antiarrhythmic drug therapy.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  American Journal of Cardiology

• Publication date

  1993-08-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(93)90040-JPMID 8256755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Action potential prolongation and early afterdepolarizations induced by class III antiarrhythmic agents in the fetal but not in the adult rat heart

  1992cited by this paper
• Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells.

  1992cited by this paper
• Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

  1991cited by this paper
• Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone.

  1991cited by this paper
• Molecular cloning and characterization of two voltage‐gated K+ channel cDNAs from human ventricle

  1991cited by this paper
• Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes.

  1990cited by this paper
• Suppression of Lethal Ischemic Ventricular Arrhythmias by the Class III Agent E4031 in a Canine Model of Previous Myocardial Infarction

  1990cited by this paper
• Cloning and expression of the delayed-rectifier IsK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus.

  1990cited by this paper
• Time-dependent outward current in guinea pig ventricular myocytes. Gating kinetics of the delayed rectifier

  1990cited by this paper
• Relative roles of Ca2(+)-dependent and Ca2(+)-independent mechanisms in hypoxic contractile dysfunction.

  1990cited by this paper
• Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death

  1990cited by this paper
• The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.

  1990cited by this paper
• Lack of Triggered Automaticity Despite Repolarization Abnormalities due to Bepridil and Lidoflazine

  1990cited by this paper
• Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents

  1990cited by this paper
• Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.

  1989cited by this paper
• Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.

  1989cited by this paper
• Amiodarone blocks calcium current in single guinea pig ventricular myocytes.

  1989cited by this paper
• Early Afterdepolarizations: Mechanism of Induction and Block A Role for L‐Type Ca2+ Current

  1989cited by this paper
• The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis.

  1988cited by this paper
• Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation.

  1988cited by this paper
• Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents.

  1987cited by this paper
• Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death.

  1987cited by this paper
• Quinidine-induced inhibition of transient outward current in cardiac muscle.

  1987cited by this paper
• Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

  1986cited by this paper
• Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.

  1986cited by this paper
• Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

  1986cited by this paper
• Effects of encainide and its metabolites on energy requirements for defibrillation.

  1986cited by this paper
• Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.

  1985cited by this paper
• Action Potential Prolongation and Induction of Abnormal Automaticity by Low Quinidine Concentrations in Canine Purkinje Fibers Relationship to Potassium and Cycle Length

  1985cited by this paper
• Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.

  1985cited by this paper
• Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.

  1984cited by this paper
• Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

  1984cited by this paper
• [Bepridil and torsades de pointes].

  1983cited by this paper
• Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.

  1983cited by this paper
• Bépridil et torsades de pointes.

  1983cited by this paper
• In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.

  1981cited by this paper
• Long-term antiarrhythmic therapy with acetylprocainamide.

  1981cited by this paper
• Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.

  1981cited by this paper
• Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.

  1980cited by this paper
• Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.

  1979cited by this paper
• The adrenergic antagonism of amiodarone.

  1976cited by this paper
• A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

  1970cited by this paper
• Electrophysiological and Beta‐Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue

  1970cited by this paper
• The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle

  1970cited by this paper
• Comparison of lidoflazine and quinidine in prophylactic treatment of arrhythmias

  year unknowncited by this paper

• Amiodarone irrecoverably impairs the function of human ether-a-go-go-related gene potassium channels

  2025cites this paper
• Update on Antiarrhythmic Therapy: Dofetilide

  2022cites this paper
• Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?

  2017cites this paper
• Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts.

  2016cites this paper
• The inhibitory effects of nifedipine on outward voltage-gated potassium currents in mouse neuroblastoma N2A cells

  2016cites this paper
• The Inhibitory Effects of Ca2+ Channel Blocker Nifedipine on Rat Kv2.1 Potassium Channels

  2015cites this paper
• Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats

  2014cites this paper
• Flavones: an important scaffold for medicinal chemistry.

  2014cites this paper
• Quetiapine and the Need for a Thorough QT/QTc Study

  2014influential citation
• Dealing with Global Safety Issues

  2013cites this paper
• Chapter 18 – Clinical Pharmacology of Antiarrhythmic Drugs

  2013cites this paper
• Effects of L-type Calcium Channel Antagonists Verapamil and Diltiazem on fKv1.4ΔN Currents in Xenopus oocytes

  2013cites this paper
• Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes

  2012cites this paper
• Dofetilide

  2012cites this paper
• Ibutilide

  2012cites this paper
• QT Prolongation Is a Poor Predictor of Proarrhythmia Liability: Beyond QT Prolongation!

  2011cites this paper
• Oscillations of cardiac wave length and proarrhythmia

  2010cites this paper
• The biological potential of flavones.

  2010cites this paper
• Interventional Role of Piperazine Citrate in Barium Chloride Induced Ventricular Arrhythmias in Anaesthetized Rats

  2009cites this paper
• Anterograde Synaptic Transport of Neuronal Tracer Enzyme (WGA-HRP): Further Studies with Rab3A-siRNA in Rats

  2009cites this paper
• Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs

  2008cites this paper
• QT prolongation is an unreliable predictor of ventricular arrhythmia.

  2008cites this paper
• Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.

  2008cites this paper
• Piperazine Protects the Rat Heart Against Sudden Cardiac Death From Barium Chloride-Induced Ventricular Fibrillation

  2008cites this paper
• Congenital Long QT Syndrome

  2008cites this paper
• Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration.

  2007cites this paper
• Cardiac Repolarisation and Drug Regulation

  2007cites this paper
• Adenoviral Expression of IKs Contributes to Wavebreak and Fibrillatory Conduction in Neonatal Rat Ventricular Cardiomyocyte Monolayers

  2007cites this paper
• Electrophysiological properties of human adipose tissue-derived stem cells.

  2007cites this paper
• Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain

  2007cites this paper
• Clinical Pharmacology of Antiarrhythmic Drugs

  2007cites this paper
• Torilin fromTorilis japonica (Houtt.) DC. Blocks hKv1.5 channel current

  2006cites this paper
• Effects of oxypeucedanin on hKv1.5 and action potential duration.

  2005cites this paper
• hERG Assay, QT Liability, and Sudden Cardiac Death

  2005cites this paper
• Open channel block of hKv1.5 by psoralen fromHeracleum moellendorffii hance

  2005cites this paper
• Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents.

  2005cites this paper
• Pharmakokinetik und Pharmakodynamik von Sotalol bei Kindern mit tachykarden Herzrhythmusstörungen und Entwicklung einer intravenösen Mikrodialysetechnik zur blutentnahmefreien Bestimmung von Sotalolplasmakonzentrationen

  2005cites this paper
• {Omega}-3 and {omega}-6 polyunsaturated fatty acids block HERG channels.

  2005cites this paper
• (cid:1) -3 and (cid:1) -6 polyunsaturated fatty acids block HERG channels

  2005cites this paper
• Open channel block of hKv1.5 by psoralen fromHeracleum moellendorffii hance

  2005cites this paper
• Case of Polymorphic Ventricular Tachycardia in Diphenhydramine Poisoning

  2004cites this paper
• Papaverine Blocks hKv1.5 Channel Current and Human Atrial Ultrarapid Delayed Rectifier K+ Currents

  2003cites this paper
• Stereoselective Drug-Channel Interactions

  2003cites this paper
• Drug interaction between mosapride and erythromycin without electrocardiographic changes.

  2003cites this paper
• Protein kinase C is necessary for recovery from the thyrotropin-releasing hormone-induced r-ERG current reduction in GH3 rat anterior pituitary cells

  2003cites this paper
• Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency.

  2003cites this paper
• Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes

  2003cites this paper
• Protein kinase C is necessary for recovery from the thyrotropin‐releasing hormone‐induced r‐ERG current reduction in GH3 rat anterior pituitary cells

  2003cites this paper
• IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines

  2003cites this paper
• Role of the 293b-sensitive, slowly activating delayed rectifier potassium current, i , in pacemaker activity of rabbit isolated

  2002cites this paper
• The Long QT Syndrome

  2002cites this paper
• Role of the 293b-sensitive, slowly activating delayed rectifier potassium current, i(Ks), in pacemaker activity of rabbit isolated sino-atrial node cells.

  2002cites this paper
• Review Article The Long QT Syndrome

  2002cites this paper
• Differences in action potential and early afterdepolarization properties in LQT2 and LQT3 models of long QT syndrome

  2001cites this paper
• A kinetic study on the stereospecific inhibition of KCNQ1 and IKs by the chromanol 293B

  2001cites this paper
• Alosetron and the rapid component of delayed rectifying potassium current in cardiac cells.

  2001cites this paper
• Controlling potassium channel activities: Interplay between the membrane and intracellular factors

  2001cites this paper
• Neonatal long QT syndrome and sudden cardiac death.

  2000cites this paper
• Potassium channels: molecular defects, diseases, and therapeutic opportunities.

  2000cites this paper
• Time‐dependent block of the slowly activating delayed rectifier K+ current by chromanol 293B in guinea‐pig ventricular cells

  2000cites this paper
• Inhibitory effect of 1-(2, 6-dimethylphenoxy)-2-(3, 4-dimethoxyphenyl-ethylamino) propane hydrochloride on inward rectifier and delayed rectifier K+ currents in guinea pig ventricular myocytes.

  2000cites this paper
• Inhibition of HERG potassium channels by the antimalarial agent halofantrine

  2000cites this paper
• Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.

  2000influential citation
• Di erences in action potential and early afterdepolarization properties in LQT 2 and LQT 3 models of long QT syndrome

  2000cites this paper
• Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide

  2000cites this paper
• 9 LONG QT SYNDROMES

  2000cites this paper
• Hypokalemia‐Induced Long QT Syndrome with an Underlying Novel Missense Mutation in S4‐S5 Linker of KCNQ1

  2000cites this paper
• Preclinical In Vitro Cardiac Electrophysiology

  1999cites this paper
• Dofetilideof its Use in Atrial Fibrillation and Atrial Flutter

  1999cites this paper
• Rate and Time Dependent Effects of D‐Sotalol on the Monophasic Action Potential After Sudden Increase of the Heart Rate

  1999cites this paper
• Block of voltage-gated potassium channels by acidic pH and Class III antiarrhythmic agents

  1999cites this paper
• Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium.

  1999cites this paper
• Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.

  1999cites this paper
• Antiarrhythmic drug initiation in patients with atrial fibrillation.

  1999cites this paper
• Effects of propafenone and 5‐hydroxy‐propafenone on hKv1.5 channels

  1998cites this paper
• Comparison of the antiarrhythmic and the proarrhythmic effect of almokalant in anaesthetised rabbits.

  1998cites this paper
• The long QT syndrome: ion channel diseases of the heart.

  1998cites this paper
• Cisapride‐Induced Torsades de Pointes

  1998cites this paper
• Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.

  1998cites this paper
• Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes.

  1998cites this paper
• Frequency dependence in the action of the class III antiarrhythmic drug dofetilide is modulated by altering L-type calcium current and digitalis glucoside.

  1998cites this paper
• Inhibition of the rapid component of the delayed‐rectifier K+ current by therapeutic concentrations of the antispasmodic agent terodiline

  1998cites this paper
• Effects of the chromanol 293 B , a selective blocker of the slow , component of the delayed rectifier K q current , on repolarization in human and guinea pig ventricular myocytes

  1998cites this paper
• Class III Antiarrhythmic Agents: The Next Wave

  1997cites this paper
• Comparison of QT/RR Relationship Using Two Algorithms of QT Interval Analysis for Identification of High Risk Patients for Life‐Threatening Ventricular Arrhythmias

  1997cites this paper
• Comparison of the Proarrhythmic Effect of GLG‐V‐13, a Novel Class III Antiarrhythmic Compound, in Two Rabbit Models of Torsades de Pointes Ventricular Tachycardia

  1997cites this paper
• Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.

  1997cites this paper
• Torsades de Pointes with Administration of High‐Dose Intravenous d‐Sotalol to a Patient with Congestive Heart Failure

  1997cites this paper
• Rate-independent effects of the new class III antiarrhythmic agent ambasilide on transmembrane action potentials in human ventricular endomyocardium.

  1997cites this paper
• KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane.

  1997cites this paper
• Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells.

  1997cites this paper
• Electrophysiological Effects of E 4031, a Drug with Selective Class III Properties, in Man

  1997cites this paper
• Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.

  1997cites this paper
• Structure and function of cardiac sodium and potassium channels.

  1997cites this paper
• Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.

  1997cites this paper
• Electrophysiological e ects of CI-980 , a tubulin binding agent , on guinea-pig papillary muscles

  1997cites this paper
• Electrophysiological effects of CI‐980, a tubulin binding agent, on guinea‐pig papillary muscles

  1997cites this paper
• Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?

  1997cites this paper
• Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels.

  1996cites this paper
• Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.

  1996cites this paper